119 related articles for article (PubMed ID: 9875634)
21. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
[TBL] [Abstract][Full Text] [Related]
22. HCV genotypes in patients with liver disease of different stages and severity.
Mangia A; Cascavilla I; Lezzi G; Spirito F; Maertens G; Parlatore L; Saracco G; Rizzetto M; Andriulli A
J Hepatol; 1997 Jun; 26(6):1173-8. PubMed ID: 9210601
[TBL] [Abstract][Full Text] [Related]
23. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area.
Paterlini P; Driss F; Nalpas B; Pisi E; Franco D; Berthelot P; Bréchot C
Hepatology; 1993 Jan; 17(1):20-9. PubMed ID: 8380790
[TBL] [Abstract][Full Text] [Related]
24. Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus.
Lee JH; von Wagner M; Roth WK; Teuber G; Sarrazin C; Zeuzem S
J Hepatol; 1998 Jul; 29(1):29-35. PubMed ID: 9696489
[TBL] [Abstract][Full Text] [Related]
25. Viral loads and E2/NS1 region sequences of hepatitis C virus in hepatocellular carcinoma and surrounding liver.
Park CK; Park TR; Kim YB; Kim HY; Yoo JY; Kim CH; Choo SH; Cho JM
Korean J Intern Med; 1997 Jan; 12(1):28-33. PubMed ID: 9159034
[TBL] [Abstract][Full Text] [Related]
26. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action.
Bréchot C; Jaffredo F; Lagorce D; Gerken G; Meyer zum Büschenfelde K; Papakonstontinou A; Hadziyannis S; Romeo R; Colombo M; Rodes J; Bruix J; Williams R; Naoumov N
J Hepatol; 1998 Aug; 29(2):173-83. PubMed ID: 9722197
[TBL] [Abstract][Full Text] [Related]
27. Serum PAI-1 and PAI-1 4G/5G Polymorphism in Hepatitis C Virus-Induced Cirrhosis and Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients.
El Edel RH; Essa ES; Essa AS; Hegazy SA; El Rowedy DI
Viral Immunol; 2016 Nov; 29(9):510-515. PubMed ID: 27459171
[TBL] [Abstract][Full Text] [Related]
28. HCV-associated liver cancer without cirrhosis.
De Mitri MS; Poussin K; Baccarini P; Pontisso P; D'Errico A; Simon N; Grigioni W; Alberti A; Beaugrand M; Pisi E
Lancet; 1995 Feb; 345(8947):413-5. PubMed ID: 7772123
[TBL] [Abstract][Full Text] [Related]
29. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C.
González-Peralta RP; Qian K; She JY; Davis GL; Ohno T; Mizokami M; Lau JY
J Med Virol; 1996 Jul; 49(3):242-7. PubMed ID: 8818972
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of replicating hepatitis C virus quasispecies in hepatocellular carcinoma tissues using PCR-SSCP method].
Kurosaki M; Enomoto N; Sakamoto N; Sato C
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):796-9. PubMed ID: 7563877
[No Abstract] [Full Text] [Related]
31. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
32. Detection of hepatitis C virus RNA in hepatocellular carcinoma by in situ hybridization.
Tang L; Tanaka Y; Enomoto N; Marumo F; Sato C
Cancer; 1995 Dec; 76(11):2211-6. PubMed ID: 8635023
[TBL] [Abstract][Full Text] [Related]
33. Selection of hepatitis C virus quasispecies during interferon treatment.
Sakuma I; Enomoto N; Kurosaki M; Marumo F; Sato C
Arch Virol; 1996; 141(10):1921-32. PubMed ID: 8920825
[TBL] [Abstract][Full Text] [Related]
34. [Viral hepatitis C].
Zeuzem S; Roth WK; Herrmann G
Z Gastroenterol; 1995 Feb; 33(2):117-32. PubMed ID: 7536996
[TBL] [Abstract][Full Text] [Related]
35. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
[TBL] [Abstract][Full Text] [Related]
36. Compartmentalization of hepatitis C virus variants in patients with hepatocellular carcinoma.
Pérez PS; Di Lello FA; Mullen EG; Galdame OA; Livellara BI; Gadano AC; Campos RH; Flichman DM
Mol Carcinog; 2017 Feb; 56(2):371-380. PubMed ID: 27163636
[TBL] [Abstract][Full Text] [Related]
37. Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C.
Kurosaki M; Enomoto N; Marumo F; Sato C
Virology; 1994 Nov; 205(1):161-9. PubMed ID: 7975211
[TBL] [Abstract][Full Text] [Related]
38. Quasispecies heterogeneity and constraints on the evolution of the 5' noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy.
Soler M; Pellerin M; Malnou CE; Dhumeaux D; Kean KM; Pawlotsky JM
Virology; 2002 Jun; 298(1):160-73. PubMed ID: 12093183
[TBL] [Abstract][Full Text] [Related]
39. Hypervariable region 1 of hepatitis C virus genome and response to interferon therapy.
Grahovac B; Bingulac-Popović J; Vucelić B; Hrstić I; Ostojić R; Drazić V; Balija M; Grgicević D
Clin Chem Lab Med; 2000 Sep; 38(9):905-10. PubMed ID: 11097348
[TBL] [Abstract][Full Text] [Related]
40. Expression of hepatitis C virus in hepatocellular carcinoma.
Haruna Y; Hayashi N; Kamada T; Hytiroglou P; Thung SN; Gerber MA
Cancer; 1994 May; 73(9):2253-8. PubMed ID: 7513244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
